Heart rate, anginal symptoms, and use of beta-blockers in stable coronary artery disease outpatients. The CLARIFY registry

被引:0
|
作者
Steg, P. G. [1 ]
Ferrari, R. [2 ]
Ford, I. [3 ]
Greenlaw, N. [3 ]
Tardif, J. C. [4 ]
Tendera, M. [5 ]
Abergel, H. [1 ]
Fox, K. M. [6 ]
机构
[1] Hosp Bichat Claude Bernard, AP HP, Paris, France
[2] Univ Ferrara, Salvatore Maugeri Fdn, IRCCS, Cardiovasc Res Ctr, I-44100 Ferrara, Italy
[3] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
[4] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada
[5] Med Univ Silesia, Katowice, Poland
[6] Royal Brompton Hosp, London SW3 6LY, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:340 / 340
页数:1
相关论文
共 50 条
  • [1] Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry
    Stepinska, Janina
    Marona, Milosz
    Greenlaw, Nicola
    Steg, Gabriel
    KARDIOLOGIA POLSKA, 2014, 72 (11) : 1156 - 1164
  • [2] Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease
    Steg, Ph Gabriel
    Ferrari, Roberto
    Ford, Ian
    Greenlaw, Nicola
    Tardif, Jean-Claude
    Tendera, Michal
    Abergel, Helene
    Fox, Kim M.
    PLOS ONE, 2012, 7 (05):
  • [3] Heart rate and use of beta-blockers in Mexican stable outpatients with coronary artery disease
    Antonio Alcocer-Gamba, Marco
    Martinez-Sanchez, Carlos
    Verdejo-Paris, Juan
    Ferrari, Roberto
    Fox, Kim
    Greenlaw, Nicola
    Steg Philippe, Gabriel
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2015, 85 (04): : 270 - 277
  • [4] Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry
    Tendera, Michal
    Fox, Kim
    Ferrari, Roberto
    Ford, Ian
    Greenlaw, Nicola
    Abergel, Helene
    Macarie, Cezar
    Tardif, Jean-Claude
    Vardas, Panos
    Zamorano, Jose
    Steg, P. Gabriel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (01) : 119 - 124
  • [5] Impact of beta-blockers and resting heart rate in diabetic patients with stable coronary artery disease
    Inoue, T.
    Arasaki, O.
    Kawamitsu, K.
    Kajiwara, K.
    Shinzato, Y.
    Ishikawa, N.
    Yamamoto, A.
    Sunagawa, O.
    Katsumata, Y.
    Ueda, S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 463 - 464
  • [6] Prevalence of Anginal Symptoms and Myocardial Ischemia and Their Effect on Clinical Outcomes in Outpatients With Stable Coronary Artery Disease Data From the International Observational CLARIFY Registry
    Steg, Philippe Gabriel
    Greenlaw, Nicola
    Tendera, Michal
    Tardif, Jean-Claude
    Ferrari, Roberto
    Al-Zaibag, Muayed
    Dorian, Paul
    Hu, Dayi
    Shalnova, Svetlana
    Jose Sokn, Fernando
    Ford, Ian
    Fox, Kim M.
    JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1651 - 1659
  • [7] Heart rate management in coronary artery disease: the CLARIFY registry
    Steg, Philippe Gabriel
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0D) : D13 - D18
  • [8] Beta-Blockers, Calcium Channel Blockers, and Mortality in Stable Coronary Artery Disease
    Jose B. Cruz Rodriguez
    Haider Alkhateeb
    Current Cardiology Reports, 2020, 22
  • [9] Beta-Blockers, Calcium Channel Blockers, and Mortality in Stable Coronary Artery Disease
    Cruz Rodriguez, Jose B.
    Alkhateeb, Haider
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (03)
  • [10] Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
    Sorbets, Emmanuel
    Greenlaw, Nicola
    Ferrari, Roberto
    Ford, Ian
    Fox, Kim M.
    Tardif, Jean-Claude
    Tendera, Michal
    Steg, Philippe Gabriel
    CLINICAL CARDIOLOGY, 2017, 40 (10) : 797 - 806